Mirabegron-induced brown fat activation does not exacerbate atherosclerosis in mice with a functional hepatic ApoE-LDLR pathwayZhixiong Ying(Leiden University Medical Center), Sander Kooijman(Leiden University Medical Center)Pharmacological ResearchDecember 24, 202210.1016/j.phrs.2022.106634Cited by 11SaveCiteExport RISWatch citationsRelated PapersTime-restricted feeding attenuates hypercholesterolaemia and atherosclerosis development during circadian disturbance in APOE∗3-Leiden.CETP mice|EBioMedicine|2023|31Combined GIP receptor and GLP1 receptor agonism attenuates NAFLD in male APOE∗3-Leiden.CETP mice|EBioMedicine|2023|21Combined glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonism attenuates atherosclerosis severity in APOE*3-Leiden.CETP mice|Atherosclerosis|2023|18